All stock lists
Avenue Therapeutics, Inc. (ATXI)
United States · Delayed Price · Currency is USD
Healthcare
0.40+0.02 (+3.90%)
Insider Score
––Not scored
ATXI Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
ATXI Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 1.40 M | — |
| Revenue Growth (YoY) | -100.00 % | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — |
| SG&A Expense | 460.00 K | 514.00 K | 698.00 K | 547.00 K | 915.00 K | — |
| R&D Expense | 247.00 K | 200.00 K | 257.00 K | 177.00 K | 192.00 K | — |
| Operating Expenses | 707.00 K | 714.00 K | 955.00 K | 724.00 K | 1.11 M | — |
| Operating Income | -707.00 K | -714.00 K | -955.00 K | -724.00 K | 297.00 K | — |
| Pretax Income | -690.00 K | -695.00 K | -726.00 K | -692.00 K | 329.00 K | — |
| Tax Provision | — | — | — | — | — | — |
| Net Income | -690.00 K | -695.00 K | -709.00 K | -683.00 K | 335.00 K | — |
| EPS (Basic) | -0.21 | -0.21 | — | -0.21 | 0.11 | -0.62 |
| EPS (Diluted) | -0.21 | -0.21 | — | -0.21 | 0.11 | -0.62 |
| Shares Outstanding | 3.29 M | 3.29 M | — | 3.18 M | 3.18 M | 2.97 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.